GlobeNewswire Inc.··Researchandmarkets.ComInfanrix Vaccines Poised for Strong Growth as Emerging Markets Expand Immunization Programs
Infanrix vaccines experience robust growth driven by rising birth rates in emerging economies, expanded immunization programs, and increased vaccine manufacturing investments through 2035.
GSKcold chain logisticsInfanrix